<DOC>
	<DOCNO>NCT00364793</DOCNO>
	<brief_summary>The primary purpose study find dose Efavirenz young child . The safety medication tolerate also study .</brief_summary>
	<brief_title>Safety , Tolerability Pharmacokinetics Efavirenz HIV-Infected Children</brief_title>
	<detailed_description />
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Didanosine</mesh_term>
	<mesh_term>Efavirenz</mesh_term>
	<mesh_term>Emtricitabine</mesh_term>
	<criteria>HIV1 infect ; &gt; =3 month age &lt; =6 year age ( time treatment ) ; screen plasma viral load &gt; =1000 copies/mL Genotypic phenotypic resistance EFV , ddl , FTC/lamivudine ( 3TC ) screening</criteria>
	<gender>All</gender>
	<minimum_age>3 Months</minimum_age>
	<maximum_age>6 Years</maximum_age>
	<verification_date>April 2014</verification_date>
	<keyword>HIV , Pediatric</keyword>
</DOC>